PLoS Pathogens (Dec 2009)

Protein C inhibitor--a novel antimicrobial agent.

  • Erik Malmström,
  • Matthias Mörgelin,
  • Martin Malmsten,
  • Linda Johansson,
  • Anna Norrby-Teglund,
  • Oonagh Shannon,
  • Artur Schmidtchen,
  • Joost C M Meijers,
  • Heiko Herwald

DOI
https://doi.org/10.1371/journal.ppat.1000698
Journal volume & issue
Vol. 5, no. 12
p. e1000698

Abstract

Read online

Protein C inhibitor (PCI) is a heparin-binding serine proteinase inhibitor belonging to the family of serpin proteins. Here we describe that PCI exerts broad antimicrobial activity against bacterial pathogens. This ability is mediated by the interaction of PCI with lipid membranes, which subsequently leads to their permeabilization. As shown by negative staining electron microscopy, treatment of Escherichia coli or Streptococcus pyogenes bacteria with PCI triggers membrane disruption followed by the efflux of bacterial cytosolic contents and bacterial killing. The antimicrobial activity of PCI is located to the heparin-binding site of the protein and a peptide spanning this region was found to mimic the antimicrobial activity of PCI, without causing lysis or membrane destruction of eukaryotic cells. Finally, we show that platelets can assemble PCI on their surface upon activation. As platelets are recruited to the site of a bacterial infection, these results may explain our finding that PCI levels are increased in tissue biopsies from patients suffering from necrotizing fasciitis caused by S. pyogenes. Taken together, our data describe a new function for PCI in innate immunity.